Related Articles
Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers
Prognostic value of programmed cell death ligand‑1 expression in the tumor‑infiltrating immune cells of patients with lung cancer: A meta‑analysis
Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma
Survival analysis with regard to PD‑L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors
Expression of PD‑L1 and CD4+ tumor‑infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma